Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ASTRAZENECA : Credit Suisse remains its Buy rating

10/20/2021 | 10:00am EST

In his latest research note, analyst Dominic Lunn confirms his positive recommendation. The broker Credit Suisse is keeping its Buy rating. The target price continues to be set at GBX 9000.


ę MarketScreener with dpa-AFX Analyser 2021
All news about ASTRAZENECA PLC
11/26ADRs Close Lower; BioNTech Rises, Carnival Drops
DJ
11/26AstraZeneca examining impact of new COVID variant on vaccine, antibody cocktail
RE
11/26AstraZeneca Reportedly Studying New Variant's Impact on Vaccine
MT
11/26AstraZeneca hopeful its antibody cocktail will work on new COVID variant
RE
11/26EU eases its controls on COVID-19 vaccine exports
AQ
11/26India resumes coronavirus vaccine exports to COVAX
RE
11/26India's Serum Institute resumes Covishield vaccine exports under COVAX facility
RE
11/25Clover Bio's COVID Vaccine Candidate to Begin Phase 2 Clinical Trial as Booster Dose
MT
11/25Inaugural Asia Summit on Global Health successfully explores healthcare landscape
AQ
11/25Namibia to start destroying expired vaccines due to slow uptake
RE
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 919 M - -
Net income 2021 3 423 M - -
Net Debt 2021 25 253 M - -
P/E ratio 2021 38,1x
Yield 2021 2,51%
Capitalization 174 B 174 B -
EV / Sales 2021 5,54x
EV / Sales 2022 4,53x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 112,12 $
Average target price 137,74 $
Spread / Average Target 22,8%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC14.84%173 523
JOHNSON & JOHNSON1.82%419 109
ROCHE HOLDING AG16.05%336 162
PFIZER, INC.46.70%303 095
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049